Editor selected abstracts and commentaries
- Apparent diffusion coefficient values obtained by unenhanced MRI predicts disease-specific survival in bladder cancer.
- FDA Approves enzalutamide for the Treatment of Men with Non-Metastatic Castration-Resistant Prostate Cancer (CRPC)
- Patient's choice of health information and treatment modality for Peyronie's disease: a long-term assessment.
- Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.
- Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress.
Searchable data base of currently enrolling clinical trials
Recent data from conferences worldwide
Print publications focusing on urological cancer treatments through original commentary & articles